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Talin is a large ( 270 kDa,  2540 amino acids)
dimeric cytoskeletal protein that couples the integrin
family of ab heterodimeric cell adhesion molecules to
the actin cytoskeleton [1]. It also plays a key role in
regulating the afﬁnity of integrins for their ligands [2].
Talin contains an N-terminal FERM domain (resi-
dues 1–400) that contains binding sites for b-integrin
cytoplasmic domains [3], F-actin [4], the adaptor pro-
tein Wech [5] and also PIP-kinase type 1c [6,7], which
is part of the signalling pathway that regulates assem-
bly of integrin-mediated cellular junctions with the
extracellular matrix (ECM). The FERM domain is
linked to a large ﬂexible rod that contains a second
integrin-binding site [8], at least two actin-binding
sites [9], and multiple binding sites for the cytoskeletal
protein vinculin [10], which is involved in stabilizing
cell–ECM junctions [11].
There are two talin genes in vertebrates, which have
conserved intron–exon boundaries and encode very
similar proteins (74% amino acid sequence identity)
[12,13]. However, talin 1 has relatively small introns
resulting in a gene of  30 kb, whereas talin 2 is much
bigger (coding sequence  190 kb), owing to the pres-
ence of larger introns. Talin 2 is predicted to be the
ancestral gene, and it appears to have undergone
duplication in chordates prior to the emergence of
vertebrates to produce talin 1 [13]. Talin gene duplica-
tion also occurred in the Amboebozoa, and Dictyoste-
lium discoideum has two talin genes, TalA and TalB,
which encode proteins with distinct functions: TalA is
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Talins are large adaptor proteins that link the integrin family of adhesion
molecules to F-actin. In vertebrates, there are two talin genes. Talin 1 is
essential for integrin-mediated cell adhesion; the role of talin 2 is unclear.
Here we report a detailed analysis of mammalian talin 2. This reveals the
existence of a previously unrecognized promoter associated with a CpG
island, and separated from the ﬁrst coding exon by numerous alternatively
spliced noncoding exons spanning > 200 kb. Analysis of a mouse gene
trap line shows that this promoter accounts for most of the talin 2 expres-
sion in adult tissues. We also demonstrate that testis and kidney express
truncated talin 2 isoforms that lack the N-terminal half of the protein, and
provide evidence for the developmentally regulated expression of the short
testis-speciﬁc talin 2 isoform in elongating spermatids. Finally, we identify
four tissue-speciﬁc alternative splicing events within the coding region of
talin 2.
Abbreviations
DAPI, 4¢,6-diamidino-2-phenylindole dihydrochloride; E2F, elongation factor 2; ECM, extracellular matrix; ES, ectoplasmic specialization;
EST, expressed sequence tag; ETS, E-twenty-six; GFP, green ﬂuorescent protein; TF, transcription factor; Tln2, mouse talin 2 gene;
TLN2, human talin 2 gene; X-gal, 5-bromo-4-chloro-3-indolyl-b-D-galactopyranoside.
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cytokinesis, whereas TalB is required for the force
transmission required to support morphogenetic move-
ments during differentiation [14].
Studies in mammalian systems have largely focused
on talin 1, which is ubiquitously expressed, and is
implicated in a wide variety of integrin-mediated
events. At the cellular level, disruption of both talin 1
alleles (Tln1) in mouse ES cells conﬁrms previous
ﬁndings that talin 1 is required for the assembly of
integrin-containing cell–ECM junctions (focal adhe-
sions) [15]. However, in lymphoid cells, integrins also
mediate cell–cell interactions, and talin 1 is required
for T-cell receptor-mediated clustering and polariza-
tion of integrin aLb2 (lymphocyte function-associated
antigen-1) and the regulation of its afﬁnity for inter-
cellular adhesion molecule-1, and for the assembly of
the immunological synapse [16]. Talin 1 also regulates
the afﬁnity of lymphocyte integrin a4b1 (very late
antigen-4) for vascular cell adhesion molecule-1 on
endothelial cells, which is important for lymphocyte
trafﬁcking [17], and in macrophages, talin 1 is
required for phagocytosis mediated by aMb2 integrin
[18]. In mice, disruption of both Tln1 alleles results in
embryonic lethality at 8.5–9.5 days post coitum, owing
to gastrulation defects [19], and more recent studies,
using a conditional Tln1 allele, have demonstrated
that talin 1 is required for the activation of platelet
integrins in vivo [20,21], for the integrity of the myo-
tendinous junction in skeletal muscle [22], and for the
association of the plasma membrane with the cyto-
skeleton in megakaryocytes [23].
The role of talin 2 is much less clear. Northern
blotting initially suggested that in the mouse, Tln2
expression was more restricted than Tln1 expression,
and Tln2 mRNAs were most abundant in heart, brain
and skeletal muscle [12]. However, more recent wes-
tern blotting data and expression studies with a
mouse gene trap line suggest that Tln2 may be more
widely expressed [24,25]. The interpretation of pub-
lished immunocytochemical studies on the expression
and cellular localization of talin in tissues is compli-
cated by the fact that many of the commonly used
talin antibodies cross-react with both proteins,
although studies with isoform-speciﬁc antibodies have
recently been published. Talin 2, but not talin 1, was
localized to the costameres and intercalated discs in
cardiomyocytes [25], whereas talin 1 and talin 2 were
both localized in the myotendinous junction, which
may explain why mice with a muscle-speciﬁc inactiva-
tion of Tln1 have an only mildly dystrophic pheno-
type [26]. Talin 2 is reportedly the most abundant
isoform in brain [25], and is found in the synapse,
where a talin 2–PIP-kinase type 1c complex is
thought to play a role in clathrin-mediated endocyto-
sis [27]. Surprisingly, mice homozygous for a Tln2
b-Geo gene trap inserted in intron 28 are viable and
fertile [24], suggesting either that talin 2 is not essen-
tial or that the talin 2–b-galactosidase fusion protein
contains the key functional elements of the talin 2
protein. Northern blot data also suggest that the gene
trap insertion only ablates Tln2 mRNA in a subset of
tissues, such as heart and testis, as some residual
expression is detected in other tissues, e.g. brain and
kidney [24]. Thus, splicing out of the gene trap may
well lead to expression of low levels of wild-type
talin 2. A completely null allele will be required to
address these issues.
Most mouse tissues express several large Tln2 tran-
scripts, ranging in size from 7 to 10 kb, and smaller
Tln2 transcripts have been detected in testis (4.8 kb)
and kidney (3.9 kb), although these are too short to
encode the full-length protein [12,24]. In order to fully
characterize the structure of talin 2, to understand the
origins and functions of its multiple transcripts, and to
inform the design of future knockout and knockdown
experiments, we report here a detailed analysis of Tln2
based on in silico, RT-PCR and functional genomic
approaches.
Results
Mouse Tln2 spans 414 kb and contains multiple
5¢ noncoding exons
Initial studies on human and mouse talin 1 and talin 2
showed that, although they share the same genomic
structure, talin 2 is a much larger gene, owing to the
larger size of the talin 2 introns [12,13]. Analysis of
mouse expressed sequence tags (ESTs) and cDNAs
covering the 5¢-end of mouse Tln2 now reveals an
additional eight 5¢-exons spanning 236 kb (Fig. 1A
and Table S2). These exons do not encode any ORF
in-frame with the rest of the Tln2 coding sequence,
and to reﬂect the absence of coding potential, we
numbered them exon )7 (most 5¢) to exon 0 with
respect to the ﬁrst known coding exon (exon 1). The
two most 5¢ exons are embedded in a 1.45 kb CpG
island (Fig. 1A). To conﬁrm the presence of tran-
scripts containing both the ﬁrst coding exon (exon 1)
and the most 5¢ exon (exon )7), we used RT-PCR on
mRNAs isolated from 13 tissues. Sequencing of the
248 bp amplicon detected in all tissues (Fig. 1B)
revealed that it contains exon )7, exon )5, exon )2
and exon 1; this is identical to the combination found
in EST BQ964581.1 (Fig. 1A). Other alternatively
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some tissues, e.g. brain (Figs 1B and S1). These
results: (a) show that previously uncharacterized alter-
natively spliced 5¢-exons are present in Tln2 tran-
scripts; (b) suggest that they originate from a new
ubiquitous promoter lying within a CpG island; and
(c) demonstrate that Tln2 is much larger ( 414 kb)
than previously thought.
In order to establish that Tln2 does not extend fur-
ther in the 5¢ direction, we generated RACE cDNA
libraries using total RNA from mouse brain and
heart. Two rounds of ampliﬁcation with nested prim-
ers in exon )7 revealed the presence of a diffuse
150 bp fragment compatible with a transcription start
site in or near the CpG island (data not shown).
Cloning and sequencing of the PCR products con-
ﬁrmed that the 5¢-end of the Tln2 transcripts lies
within the CpG island, although the transcription
start site varied slightly within the same tissue and
also between tissues (Fig. 1C). This may reﬂect the
absence of a TATA-box, and suggests that the
Tln2 promoter associated with the CpG island is a
A 
B 
D 
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Fig. 1. The 5¢-end of mouse Tln2 is associated with a CpG island and contains a large number of 5¢-UTR exons scattered over 200 kb. (A)
Schematic diagram of the 5¢-region of mouse Tln2 and corresponding ESTs. Tln2 is transcribed from the minus strand; consequently, the
mouse chromosome 9 telomere is on the left (Tel.) and the centromere is on the right (Cen.). Boxes represent previously known exons;
dashed boxes denote new putative exons and are linked to the rest of Tln2 by a dashed line. The ﬁrst codon (ATG) is in exon 1, which con-
tains both noncoding and coding sequences. Noncoding exons (grey) are numbered from 0 to )7. The CpG island associated with exon )7
is represented by a grey rectangle. The identity and position of the gene trap insertion downstream of exon )3 are indicated. Below the
genomic structure, ESTs are shown that contain different combinations of Tln2 exons. The distance between the exons is indicated in bp,
and the oblique lines represent splicing events. (B) RT-PCR between exon )7 and exon 1 (primers a + b) revealed widespread expression of
Tln2 from the CpG island region in adult mouse tissues. Gen., genomic DNA; H2O, negative water control; RT+, reversed-transcribed RNA;
RT), non-reversed transcribed control. Gapdh primers were used to assess the amount of cDNA used in PCR reactions. Br., brain; H., heart;
K, kidney; Ts, testis; Th, thymus; Lu, lung; SI, small intestine; LI, large intestine; M, skeletal muscle; Sp, spleen; Lv, liver; St, stomach; Sk,
skin. (C) 5¢-RACE anchored in exon )7 conﬁrmed the 5¢-end of Tln2. The sequence of exon )7 and ﬂanking 5¢ and 3¢ (lower-case) sequences
are shown. The position of the RACE primers in exon )7 is indicated by half-arrows. The RACE products obtained were cloned and
sequenced. The position of the transcriptional start sites is indicated by squares and circles in brain and kidney respectively. The number of
clones obtained at each position is also shown. (D) The gene trap insertion downstream of exon )3 dramatically reduces levels of talin 2 in
mouse adult tissues. Proteins from wild-type (wt) and homozygous gene trap (gt⁄gt) mice were analysed by western blotting. Equal amount
of total proteins were loaded, and talin 2 was detected with a monoclonal antibody against talin 2 (epitope within residues 482–991). Vinculin
was used as an additional loading control and as a normalization reporter to quantify the reduction in Tln2 expression by luminometry (% of
residual talin 2). The reduction in talin 2 levels was  80% in brain, 63% in heart, 93% in kidney, and 97% in spleen.
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of various combinations of transcription factors
(TFs) for transcription initiation [28,29]. Analysis of
the 5¢-end of human TLN2 conﬁrms that, as in
mouse, transcription is driven from a CpG island sit-
uated  200 kb away from the ﬁrst coding exon,
and that the 5¢-UTR exons, some of which are con-
served between mouse and human, show complex
patterns of alternative splicing in different cell types
(Table 1 and Fig. S2).
In silico identiﬁcation of a conserved minimal
promoter associated with the CpG island
As the CpG island is conserved in other mammals
(data not shown), we sought to establish whether a
conserved promoter is present in the vicinity. We used
two different in silico methods (frameworker and
dialign tf; Genomatix) to analyse a 2.2 kb segment
upstream of exon )7 in six different mammalian
species (Fig. S3 and Experimental procedures). Both
approaches revealed the presence of the same highly
conserved cluster of TF-binding sites just upstream of
the transcriptional start sites identiﬁed by 5¢-RACE in
the mouse CpG island. The arrangement and position
of these sites is strictly conserved in six different spe-
cies, and they are predicted to recruit ubiquitously
expressed TFs, such as nuclear respiratory factor 1,
elongation factor 2 (E2F), cAMP-responsive element
binding protein and E-twenty-six (ETS), which are
associated with a large number of ubiquitously
expressed housekeeping genes [30]. These results
strongly suggest that a core promoter is embedded
within the CpG island at the 5¢-end of the mammalian
gene, and that its use underlies the ubiquitous expres-
sion of Tln2 transcripts (Fig. 1B). Furthermore, exami-
nation of chromatin modiﬁcation data supplied with
the latest human genome build (ensembl v50; Fig. S4)
strongly supports the idea of a promoter associated
with the CpG island in humans. Indeed, it indicates
that a 298 bp region overlapping our minimal pro-
moter bears chromatin features characteristics of a
promoter, i.e. presence of histone H2AZ, H3K9
monomethylation, H3K4 dimethylation and trimethy-
lation, and DNAse I hypersensitivity (Fig. S4). It also
suggests that, at least in humans, no other sequences
upstream of the ﬁrst coding exon exhibit the same
features, and therefore that a single promoter may
control the expression of TLN2.
Transcription from the CpG island accounts for
the majority of Tln2 expression in adult tissues
To get a better insight into the functional signiﬁcance
of the CpG island and its associated promoter, we
analysed mice carrying a gene trap insertion in the
intron downstream of exon )3 (Fig. 1A and Experi-
mental procedures), which should interrupt transcrip-
tion from the CpG region. Mice homozygous for the
gene trap (gt⁄gt) were viable, and we therefore analy-
sed talin 2 levels in various tissues (brain, heart,
kidney and spleen) by western blotting (Fig. 1D).
Strikingly, the gene trap insertion led to a dramatic
reduction in talin 2 levels in all four tissues (Fig. 1D).
This indicates that the region upstream of exon )3
contains one or several major site(s) of transcription
initiation. It also strongly suggests that the promoter
identiﬁed in this study is a major Tln2 promoter.
However, the gene trap failed to completely ablate
talin 2 expression. This could be due to the intrinsic
properties of gene traps, as skipping of gene trap cas-
settes and alternative splicing around the transgene
have previously been described [31–33]. Alternatively,
it is possible that other Tln2 promoters exist
Table 1. Conservation of 5¢-UTR talin 2 exons in humans. ), minus strand; +, plus strand; ND, not detected; NA, not applicable.
Mouse Location on chromosome 9
Distance to ﬁrst
coding exon (bp)
Conservation on human
chromosome 15
Distance to ﬁrst coding
exon in humans (bp)
CpG island 67 480 506–67 481 954 236 635 60 469 795–60 471 688 255 081
Exon )7 67 481 698–67 481 838 ()) 236 519 60 470 017–60 470 174 (+) 256 595
Exon )6 67 480 721–67 481 441 ()) 236 122 60 470 426–60 471 217 (+) 255 552
Exon )5 67 407 421–67 407 510 ()) 162 191 60 555 817–60 555 905 (+) 170 864
Exon )4 67 387 385–67 387 419 ()) 142 100 ND NA
Exon )3 67 387 139–67 387 210 ()) 141 891 ND NA
Exon )2 67 307 723–67 307 796 ()) 62 477 60 669 179–60 669 251 (+) 57 518
Exon )1 67 276 569–67 276 610 ()) 31 291 ND NA
Exon 0 67 252 059–67 252 157 ()) 6838 60 716 850–60 716 923 (+) 9846
Exon 1 67 245 319–67 245 490 ()) NA 60 726 769–60 726 937 (+) NA
ATG 67 245 487 ()) NA 60 726 802 (+) NA
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the extent of the reduction in talin 2 level observed
strongly suggests that transcription upstream of the
gene trap, most likely from the promoter in the CpG
island, is responsible for the majority of talin 2
production in adult tissues.
A
B
C
D
Fig. 2. A shorter Tln2 transcript and protein product are speciﬁcally expressed in testis. (A) Schematic diagram of the mouse genomic region
between coding exons 25 and 56, showing the gene trap insertion downstream of exon 28. The two testis ESTs containing additional
exons 25b and 25c are shown under the genomic region. Grey boxes represent noncoding exons; white boxes are coding sequences. The
additional amino acid sequence encoded by exon 25c is indicated. The position of the epitope recognized by the C-terminal polyclonal and
monoclonal antibodies (Ab) is shown (encoded by exon 55). Half-arrows represent primers used in RT-PCR. RT-PCR ampliﬁcation after 30
cycles and 40 cycles (testis) using primers d + e are depicted on the right-hand side. Gen., genomic DNA; H2O, negative water control;
RT+, reversed-trascribed RNA; RT), non-reversed-transcribed control. Br, brain; H, heart; K, kidney; Ts, testis; Th, thymus; Lu, lung; SI, small
intestine; LI, large intestine; M, skeletal muscle; Sp, spleen; Lv, liver; St, stomach; Sk, skin. (B) 5¢-RACE conﬁrms the 5¢-end of short testis-
speciﬁc Tln2 transcripts. The sequence of exon 25b is shown – the position of ESTs is highlighted in grey; the position of the RACE primer
is indicated by a half-arrow; and the position of the 5¢-ends of three sequenced RACE amplicons is marked by a star. (C) Alignment of the
predicted N-termini of the truncated testis-speciﬁc talin 2 isoforms with the full-length talin 2. +Ex25C, translation of transcripts containing
exon 25c using the in-frame ATG present in exon 25c; )Ex25c, translation of short transcripts in which exon 25c is skipped (exons 25b + 26
to 56), using the next ATG in exon 26. The colour wrapping indicates identical amino acids in two (blue) or three (yellow) sequences; green
represents positions occupied by different but structurally similar amino acids. (D) Western blotting of protein extracts from wild-type (wt)
and homozygous gene trap (gt⁄gt) mice. Left panel: probed with a C-terminal polyclonal anti-talin 2 antibody [see (A) and Experimental
procedures]. Right panel: probed with a polyclonal antibody against b-galactosidase. Br, brain; Ts, testis. The table indicates the predicted
molecular masses of proteins detected by the two antibodies.
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spermatids of the mature testis
Northern blots of testis mRNA reveal a 4.8 kb Tln2
transcript that is too small to encode the full-length
protein [12,24]. A testis EST containing two new 5¢-ex-
ons (25b and 25c; Fig. 2 and Table S2) and predicted
to encode a talin 2 lacking the talin head and half of
the rod domain has also been described [24]. To ana-
lyse the expression pattern of exons 25b and 25c, we
performed RT-PCR on a panel of tissues with primers
located in exons 25b and 26 (Fig. 2A). This revealed
high-level expression of exon 25b speciﬁcally in testis
and very low levels in thymus. Surprisingly, the main
RT-PCR amplicon in testis is too short to contain
exons 25b, 25c and 26, although a minor larger prod-
uct was also observed (Fig. 2A, 40 cycles). Both prod-
ucts were sequenced, and this revealed that skipping of
exon 25c occurs in a proportion of transcripts.
Exon 25b is predicted to be noncoding, whereas
exon 25c harbours 84 bp of noncoding sequence and
an ATG at position 85–87 in-frame with the full-length
Tln2 ORF [24]. Use of this ATG would add a unique
30 amino acid sequence to the N-terminus of this trun-
cated talin 2 isoform, which otherwise would be identi-
cal to residues 1121–2542 of the C-terminal half of
full-length talin 2. However, the above RT-PCR data
suggest that a second protein product may result from
the skipping of exon 25c. In this case, the transcript
would contain a unique 5¢-UTR, and the next in-frame
ATG would be located in exon 26. Consequently, the
protein would not contain the N-terminal 30 amino
acid extension (Fig. 2C), and would be equivalent to
residues 1153–2541 of full-length talin 2. To investigate
whether exon 25b encodes the 5¢-end of the short testis
transcript, we ﬁrst carried out quantitative RT-PCR.
This showed that Tln2 transcripts possessing sequences
downstream of exons 25b and 25c are 20 times more
abundant in testis than transcripts initiating upstream
of exon 25 (Fig. S5A). This strongly suggests that the
vast majority of Tln2 transcripts in testis initiate down-
stream of exon 25. 5¢-RACE experiments conﬁrmed
that exon 25b represents a genuine Tln2 transcription
start site in testis. The position of the start site varies
slightly in the three clones that we sequenced, and no
TATA-box was detected upstream of exon 25b
(Fig. 2B). From the above results, we conclude that
these short Tln2 transcripts are expressed at high levels
speciﬁcally in testis, and that they contain a unique
5¢-end composed of either exon 25b or exons 25b
and 25c.
To establish whether the  4.8 kb Tln2 transcripts
in testis gives rise to truncated talin 2 protein(s), we
used a gene trap mouse line [24] in which the transgene
is inserted between exons 28 and 29 (Fig. 2A). Because
the gene trap cassette is downstream of exons 25b and
25c, it is predicted to interrupt the transcription of
both long (ubiquitous) and short (testis-speciﬁc) Tln2
transcripts. If full-length talin 2 (270 kDa) and the
shorter isoforms (153 kDa) coexist in testis, they
should both be detected in wild-type animals with an
antibody raised against the C-terminal region of
talin 2, whereas both proteins should be absent in
homozygous gene trap mice. Furthermore, the gene
trap cassette should lead to the expression of two
talin 2–bGeo fusion proteins that can be detected by
an antibody against b-galactosidase (Fig. 2D). As pre-
dicted, the levels of talin 2 proteins were dramatically
reduced in tissues from homozygous (gt⁄gt) mice, and
they were replaced by the predicted talin 2–bGeo
fusions (Fig. 2D). These results establish for the ﬁrst
time the existence of a truncated talin 2 in testis, which
we have named Ts-talin 2 (testis-talin 2). We have not
detected Ts-talin 2 in any other tissues.
As Ts-talin 2 lacks the integrin-binding site found in
the N-terminal FERM domain of full-length talin, we
sought to establish whether it could localize to cell–
ECM junctions. Analysis of NIH-3T3 cells transiently
expressing green ﬂuorescent protein (GFP)–Ts-talin 2
conﬁrmed that the protein was efﬁciently expressed
(Fig. S6A and Doc. S1), and that it localized to focal
adhesions in a similar manner to GFP–full-length
talin 2 (Fig. S6B and Doc. S1), mCherry–full-length
talin 2 or endogenous full-length talin 2 [25]. Expres-
sion of GFP–Ts-talin 2 in talin 1-deﬁcient dJ26.28 cells
[15,34] produced essentially similar results, showing
that its localization is not dependent upon talin 1 (data
not shown).
In order to further understand the role of Ts-talin 2
in testis physiology, we performed western blot analy-
sis of testis extracts from prepubertal and pubertal
mice using N-terminal and C-terminal antibodies to
detect the full-length and short testis isoforms. The
results show that Ts-talin 2 is not expressed in prepu-
bertal testis (2 weeks) but is upregulated at the onset
of puberty (4–6 weeks in the C57Bl⁄6 mouse strain).
Concomitantly, the full-length protein is downregulat-
ed (Fig. 3A). In addition, our gene trap mouse line,
which reports expression of both full-length talin 2
and Ts-talin 2 (Fig. 2A), allowed us to follow the
expression pattern of the two proteins during this
developmental switch. In heterozygotes, the b-galacto-
sidase fusion protein was expressed in myoid cells and
Leydig cells at the periphery of the seminiferous
tubules, and this pattern of expression was identical at
2 and 12 weeks of age. However, strong punctate
E. Debrand et al. Multiple talin 2 transcripts and protein isoforms
FEBS Journal 276 (2009) 1610–1628 ª 2009 University of Leicester. Journal compilation ª 2009 FEBS 1615AC
B
Fig. 3. Ts-talin 2 is developmentally regulated and is expressed in early elongating spermatids. (A) Western blotting of testis protein extracts
from two C57Bl⁄6 mice prior to (2 weeks old) and after puberty (4, 8 and 12 weeks). A talin 2 monoclonal C-terminal antibody was used to
detect both full-length talin 2 and the short Ts-talin 2 isoforms, whereas the N-terminal monoclonal antibody detected only full-length talin 2.
The respective levels of Ts-talin 2 (light blue), full-length talin 2 (dark blue) and the Ts-⁄full-length talin 2 ratio (red) were assessed by luminome-
try (average of two animals per age group; relative to vinculin loading control). (B) 5-bromo-4-chloro-3-indolyl-b-D-galactopyranoside (X-gal) stain-
ing of cryosections of 2-week-old and 12-week-old testis from animals with a gene trap insertion reporting the expression of both full-length and
Ts-talin 2 (see Fig. 2). Arrows indicate expression in myoid cells adjacent to the basement membrane of the seminiferous tubule; arrowheads
point to the staining of interstitial Leydig cells. Staining in both locations was identical in prepubertal and pubertal mice. An asterisk shows the
punctate expression detected only after puberty, restricted to speciﬁc stages of the tubule cycle and replaced by a diffuse staining of the
adluminal compartment at the point of spermiation (bracket). Left panel: 20· objective. Right panel: 40· objective. Bar = 50 lm. (C) Differential
interference contrast image of a stage XII–I seminiferous tubule squash (top panel) from a 3-month-old gene trap animal, stained with DAPI and
X-gal, and detail of two elongating spermatids (bottom panel). Arrowheads indicate b-galactosidase staining. The data show that the punctate
talin 2 expression in the mature testis, most likely Ts-talin 2, is restricted to the cytoplasm of elongating spermatids. Bar = 20 lm.
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epithelium after puberty. This was detected in only a
subset of immature tubules, and was replaced by more
diffuse staining as the tubule progressed towards the
spermiation point (Fig. 3B). Dissection of portions of
seminiferous tubules, staged by transillumination [35],
revealed that these dot-like structures are only present
between the end of stage VIII (end of spermiation),
when the transition between round and elongating
spermatids is initiated, and the end of stage I, when
elongating spermatids start forming bundles [36] (data
not shown). Squashes of tubules from stages VIII–XII
and XII–I [35] were used to analyse further the expres-
sion of the b-galactosidase–talin 2 fusion protein. This
showed that the dot-like structures are localized in the
cytoplasm of early elongating spermatids (Fig. 3C). A
proportion of dots were also observed in enucleated
vesicles (data not shown), reminiscent of the residual
bodies lost during the process of spermatid elongation
[37]. Together with our western blotting data, these
results strongly suggest that the expression of full-
length talin 2 is restricted to myoid and Leydig cells,
whereas Ts-talin 2 is characteristic of the early stages
of spermatid elongation.
A second, shorter Tln2 transcript is highly
expressed in kidney
Northern blotting detects a highly expressed 3.9 kb
Tln2 transcript in kidney [12,24]. Examination of
mouse ESTs revealed a kidney EST (AI317453) with a
novel 5¢-exon (numbered 34b) just downstream of
exon 34 (Fig. 4A and Table S2). The position of
exon 34b suggests that it may represent the ﬁrst (or
one of the ﬁrst) exon(s) of the 3.9 kb Tln2 kidney tran-
script (Fig. 4A). RT-PCR showed that exon 34b-con-
taining transcripts are expressed at very high levels in
kidney and at lower levels in brain, heart, testis, lung,
muscle, and skin (Fig. 4B). Moreover, quantitative
real-time RT-PCR showed that exon 34b transcripts
are 11 times more abundant in kidney than those initi-
ating upstream (Fig. S5B). Conversely, in small intes-
tine and brain, exon 34b transcripts are expressed at
much lower levels than the full-length transcripts
(Fig. S5B,C). Together, these results indicate that
exon 34b is part of a different Tln2 transcript that is
mainly expressed in kidney, where it is by far the most
abundant species.
To conﬁrm that exon 34b is actually the ﬁrst exon
of the 3.9 kb kidney Tln2 transcript, we performed
5¢-RACE. The data show that transcripts containing
exon 34b do not carry any further 5¢-exons (Fig. 4B).
The longest 5¢-RACE product that we have identiﬁed
does not contain any ATGs in exon 34b that are
in-frame with the rest of talin 2, so it is very likely that
exon 34b is a noncoding exon. The ﬁrst ATG in-frame
with the Tln2 ORF is found in exon 35, which is com-
mon to both long and short transcripts (Fig. 4A,C).
The corresponding truncated talin 2 isoform is
predicted to be a 90 kDa protein spanning
residues 1608–2543 (Figs 4C and 6). This isoform
should not be detected by antibodies raised against the
N-terminal region of talin 2, whereas an antibody
against the C-terminal region should detect both full-
length talin 2 and an additional 90 kDa protein,
mainly in kidney. As expected, western blotting with
the N-terminal antibody showed only full-length
talin 2 (data not shown). In contrast, two different
C-terminal antibodies detected an additional protein of
 90 kDa that was strongly expressed in kidney
(Fig. 4C and data not shown).
To investigate whether a similar talin 2 isoform is
expressed in humans, we ﬁrst probed a northern blot
using a conserved mouse Tln2 3¢-probe. As in mouse,
we observed a 3.9 kb transcript that was speciﬁcally
and highly expressed in human kidney (Fig. 4D). In
addition, a search for sequences homologous to
exon 34b in the EST database revealed the existence of
a human kidney EST (BI517694) containing at its
5¢-end the conserved counterpart of exon 34b. By
screening a human kidney cDNA library with a set of
nested primers in the conserved exon 34b and a second
primer in the vector (Sp6), we were able to amplify a
450 bp cDNA product, which was cloned and
sequenced. Alignment between the new human
sequence, the mouse 5¢-RACE product and the mouse
and human ESTs containing exon 34b revealed that
exon 34b is highly conserved between the two species,
and does not have any coding potential (Fig. 4D). We
conclude that the shorter 3.9 kb transcript and
exon 34b are conserved in humans, and, as in mice,
are highly expressed in kidney.
Alternative splicing of Tln2 coding exons
The existence of alternatively spliced transcripts has
been described in vertebrate talin 2 and in the unique
ancestral talin gene, which is closely related to talin 2
[12,13]. In order to clarify the extent of alternative
splicing in the mammalian gene, we conducted a sys-
tematic review of alternatively spliced ESTs in the
mouse. We also sought to determine the expression
proﬁle of these variants as well as their relationship to
the various short transcripts described above. We iden-
tiﬁed three genuine Tln2 splice variants in mouse ESTs
(Fig. 5A). The ﬁrst alternative splicing skips exon 43
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Fig. 4. Evidence for a truncated mouse Tln2 transcript and protein product highly expressed in kidney and conserved in human. (A) Sche-
matic diagram of the mouse Tln2 genomic region between coding exons 33 and 56. An EST containing the additional exon 34b is shown
below. Grey boxes represent noncoding exons; white boxes are coding sequences. Half-arrows indicate the primers used in RT-PCR.
RT-PCR ampliﬁcation after 35 cycles using primers f + g is shown. Gen., genomic DNA; H2O, negative water control; RT+, reversed-tran-
scribed RNA; RT), non-reversed-transcribed control. Br, brain; H, heart; K, kidney; Ts, testis; Th, thymus; Lu, lung; SI, small intestine; LI,
large intestine; M, skeletal muscle; Sp, spleen; Lv, liver; St, stomach; Sk, skin. (B) 5¢-RACE conﬁrms the 5¢-end of the short transcript. The
sequence of exon 34b is shown, and the position of the EST is shaded grey; intronic sequences are in lower case; the position of the RACE
primers is indicated by an arrow, and the positions of the 5¢-ends of two sequenced RACE amplicons are marked by a star. (C) Alignment of
the predicted N-terminus of the corresponding truncated protein with the full-length talin 2. (D) Western blotting showing the presence of a
90 kDa talin 2 protein in kidney (*). (E) Conservation of the short ‘kidney’ transcript in humans. A human tissue northern blot was probed
with a DNA fragment detecting the 3¢ coding region of TLN2. A 3.9 kb transcript strongly expressed in kidney was detected. (F) A kidney
cDNA library was screened with primers near the putative 5¢-end of the transcript and in the cloning vector. This revealed a new exon that
was also present in a human EST. The alignment of the corresponding cDNA sequences with the equivalent mouse sequences is shown.
*, 5¢-ends determined in this study.
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extension of exon 54 (exon 54b; Table S2) and inserts
15 amino acids between residues 2458 and 2459 of the
protein, is found in four distinct ESTs (brain AB093231,
CO044539 and BC079896; 8 days post coitum whole
body AK017597), and is equivalent to a splice variant
previously described in humans [13]. The third variant
EST from a mammary tumour library combines skip-
ping of exons 43 and 44 with the inclusion of exon 54b
(BC033288).
RT-PCR showed that exon 43 skipping is common
in most adult tissues (Fig. 5B; primers i + j and
i + k), although the ratio between transcripts includ-
ing or excluding exon 43 varies greatly between tissues.
Only heart, lung and skin express the exon 43-minus
variant at about the same level as the wild-type tran-
script, whereas it is found at much lower levels in
other tissues, and was totally absent from brain. In
contrast, skipping of exons 43 and 44, as found in a
mammary tumour EST, is a rare event in the tissues
tested (Fig. 5B; primers i + k). Next, we searched for
transcripts that included exon 54b. Again, this splice
variant was detected in all the tissues tested, but at
variable levels (Fig. 5C; primers m + n). Strikingly,
transcripts containing exon 54b are the major variant
in brain (Fig. 5C; primers l + n).
To search for mRNAs lacking exons 43 and 44 but
including exon 54b, we ﬁrst ampliﬁed cDNAs contain-
ing exon 54b (primers o + q), and then assessed the
splicing of either exon 43 alone or exons 43 and 44
using nested PCR (primers i + k; Fig. 5D). We did
not detect any products carrying deletions of both
exons 43 and 44 (Fig. 5D), which conﬁrmed the very
low levels previously observed in the total cDNA pop-
ulation (see above and Fig. 5B). However, transcripts
skipping exon 43 and containing exon 54b are a major
component of skin, whereas in kidney and muscle they
occur at a much lower level. We also failed to detect
exon 43 skipping in either the testis or kidney short
transcripts (Fig. S7), which suggests that skipping of
exon 43 is a speciﬁc feature of long transcripts. In con-
trast, inclusion of exon 54b was found in both the
short and long transcripts expressed in brain and
kidney, but not in heart or testis (Fig. S7). We
A 
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Fig. 5. Evidence for alternatively spliced
mTln2 transcripts. (A) Schematic diagram of
two regions showing alternative splicing.
ESTs supporting alternative splicing are
shown below the genomic region. Primers
used to detect alternative splicing (i, j, k, l,
m and n) and short transcript isoforms (d,
short testis transcript; f, short kidney tran-
script) are indicated by half-arrows. The
amino acid sequence of the in-frame pep-
tide added as a result of inclusion of
exon 54b is shown. (B, C) RT-PCR ampliﬁca-
tion after 35 cycles using various primer
combinations. (B) Primer i + j detects splic-
ing out of exon 43; i + k reveals splicing of
both exon 43 and exon 44. (C) m + n
indicates the presence of exon 54b; l + n
indicates the relative abundance of exo-
n 54a + exon55 and exon 54ab + exon 55
products. Gen., genomic DNA; H2O,
negative water control; RT+, reversed-
transcribed RNA; RT), non-reversed-
transcribed control. Br, brain; H, heart; K,
kidney; Ts, testis; Th, thymus; Lu, lung; SI,
small intestine; LI, large intestine; M,
skeletal muscle; Sp, spleen; Lv, liver; St,
stomach; Sk, skin.
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exon 43 or include exon 54b, whereas in kidney,
exon 54b is mainly added to the short transcript, and
is much less abundant in full-length Tln2 transcripts.
Together, these results provide new evidence of the
complexity of Tln2 transcription and suggest that the
gene encodes at least three different transcripts, which
are subject to alternative splicing in a tissue-speciﬁc
and⁄or isoform-speciﬁc manner.
Discussion
In the present study, we have carried out a detailed
analysis of mouse Tln2 and showed that it spans over
400 kb. This is much larger than previously reported,
owing to the presence of a new promoter associated
with a CpG island located 236 kb upstream of the ﬁrst
coding exon. This promoter drives transcription of
Tln2 mRNAs containing a number of 5¢-exons scat-
tered over  200 kb, none of which generate an ORF
in-frame with the rest of the Tln2 coding sequence. We
conclude that they are 5¢-UTR exons. These untrans-
lated exons are subject to alternative splicing, and this
probably explains why several large Tln2 transcripts
can be detected in northern blots [12,24]. The smallest
RT-PCR amplicon derived from the mouse 5¢-UTR is
composed of exons )7, )5 and )2. When this is linked
to the sequence encoding the full-length protein, it
gives rise to a 9.2 kb transcript, whereas a Tln2 tran-
script containing all of the authenticated 5¢-UTR exons
()7, )6, )5, )2 and 0) would be about 10 kb in length.
These are similar in size to the 9.5 kb and 10 kb tran-
scripts detected in northern blots [12,24]. However, we
have yet to determine the full extent of alternative
splicing of the 5¢-UTR exons. The failure to detect
transcripts containing exons )4 and )1 in adult mouse
tissues (Fig. S1) suggests that their inclusion is tissue-
speciﬁc and⁄or developmentally regulated. It also
raises the question as to whether they are ever included
in Tln2 transcripts initiating at the CpG island. Inter-
estingly, exons )4 and )1 are the most 5¢ sequences in
ESTs derived from mouse blastocysts and 13-day-old
embryo heart respectively (Fig. 1A), suggesting that
there may be alternative transcriptional start sites in
the vicinity of exons )4 and )1.
With respect to human TLN2, previous studies have
assumed that transcription is initiated at the ﬁrst base
of the ﬁrst coding exon [25]. However, we demonstrate
that some of the 5¢-UTR exons observed in the mouse
are conserved in human TLN2, and that large TLN2
transcripts exist in human tissues. Moreover, using
RT-PCR and human ﬁbroblast and heart mRNAs, we
detected additional novel 5¢-UTR exons linking exon
)7 to exon 1. Thus, the 5¢-UTR of human TLN2 is
similarly complex, although not all the 5¢-UTR exons
are conserved between human and mouse (Fig. S2).
The role of such a complex alternatively spliced
5¢-UTR is unclear, although its conservation between
species implies an important functional role. It could,
for instance, regulate the stability of the corresponding
transcripts at different levels, either intrinsically or in
response to cellular cues [38,39].
Our data in mouse show that a major Tln2 promoter
is associated with the CpG island upstream of these
5¢-UTR exons, and that this is conserved in all mam-
mals. The in silico characterization of this promoter was
based on the rationale that polymerase II promoters
usually contain multiple TF-binding sites, the spatial
organization (framework) of which deﬁnes the speciﬁc-
ity of the promoter [28,29]. Using this stringent
approach, we identiﬁed a minimal core promoter that is
conserved in mammals and contains a common frame-
work of binding sites for the ubiquitously expressed TFs
nuclear respiratory factor 1, E2F, cAMP-responsive ele-
ment binding protein and ETS-1. However, of the above
TFs, only ETS-1 has previously been implicated in cell
adhesion, via transcriptional regulation of metallopro-
teases [40]. Clearly, further experimental work will be
required to conﬁrm the role of these TFs in regulating
Tln2 expression. Interestingly, in humans, the region
that we have deﬁned as the conserved minimal promoter
is the only TLN2 sequence bearing chromatin features
characteristic of a promoter [41] (Fig. S4).
Direct experimental proof that the distal CpG region
contains a major Tln2 promoter comes from studies
with mice carrying a gene trap insertion in intron )3.
The results establish that the majority of talin 2
expressed in adult tissues is derived from transcripts
that initiate upstream of exon )3. However, the gene
trap insertion failed to totally abolish talin 2 expres-
sion, and the levels of residual talin 2 varied between
tissues. This may be due to splicing around the gene
trap, the efﬁciency of which may vary from tissue to
tissue, or to the presence of a tissue-speciﬁc pro-
moter(s) downstream of the insertion. Indeed, the exis-
tence of a muscle-speciﬁc promoter in human TLN2
just upstream of the ATG of exon 1 has been reported
[25], although the authors only identiﬁed individual
TF-binding sites in silico rather than conserved clus-
ters. If this promoter is authentic, then our data show
that it is clearly not the only promoter used in skeletal
muscle (Figs 1B, 4D and S2B).
The next level of complexity resides in the existence
of additional Tln2 promoters that give rise to short
Tln2 transcripts in certain tissues, the evidence for
which was originally based on northern blots of testis
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short Tln2 transcripts that are restricted to adult testis,
and that differ at the 5¢-end, owing to alternative splic-
ing of the ﬁrst coding exon (exon 25c). This should
result in the expression of two short talin 2 isoforms
that span residues 1121–2542 and 1153–2542 of the
full-length talin 2, the notable difference being that the
former contains a unique 30 amino acid N-terminal
extension encoded by exon 25c (Figs 2 and 6). We
have conﬁrmed by western blotting that the predomi-
nant talin 2 isoform in testis has a molecular mass of
 150 kDa and that its expression correlates with the
onset of puberty in mice. Furthermore, analysis of the
b-galactosidase–talin 2 reporter generated by the inser-
tion of a gene trap downstream of the testis-speciﬁc
transcriptional start site (intron 28; see Fig. 2) revealed
that upregulation of Ts-talin 2 at puberty correlates
with the appearance of strong and localized X-gal
staining in the cytoplasm of early elongating spermat-
ids and in enucleated vesicles, reminiscent of resid-
ual⁄cytoplasmic bodies [37]. Therefore, we propose
that Ts-talin 2 might play a key role in the regulation
of spermatid elongation and⁄or migration through the
seminiferous epithelium. These processes are thought
to involve cell–cell contacts between elongating sper-
matids and the apical ectoplasmic specializations (ESs)
of surrounding Sertoli cells. Various laminin isoforms,
integrin a6b1 heterodimers, F-actin and other cytoskel-
etal and signalling molecules have been implicated on
both sides of the spermatid–ES junction, although,
interestingly, the linker proteins between the extracellu-
lar laminins and the cytoplasm of the elongating sper-
matid are currently unknown [42,43]. If Ts-talin 2 is
important in spermatogenesis, one would predict that
spermatogenesis should be defective in mice homozy-
gous for the gene trap insertion in intron 28, which
results in a dramatic reduction in the level of Ts-
talin 2. However, these mice are viable and fertile [24].
Quantitative RT-PCR across the insertion site, and
careful examination of western blots, reveals that tran-
scription downstream of the gene trap still occurs, and
a low level of the Ts-talin 2 is still present in the testis
of these mice (data not shown). Thus, the gene trap
may well be a hypomorphic rather than a null allele,
and a more thorough investigation of the phenotype of
these mice is required.
The second short Tln2 transcript identiﬁed here con-
tains a unique 5¢ noncoding exon (34b), and was found
mainly but not exclusively in kidney. Using western
blotting, we have conﬁrmed that the corresponding
90 kDa protein is expressed in kidney, although we
have not detected it in embryonic or adult kidney
epithelial cell lines (NRK, HEK-293, Cos-7; data not
shown) or in other tissues. However, the expression of
the corresponding short transcripts in other tissues
suggests that the protein(s) may be present at low
levels, perhaps in a subset of cells. The protein is pre-
dicted to span residues 1608–2542, and therefore lacks
the N-terminal region of full-length talin 2 (Fig. 6).
Recent studies show that the N-terminal FERM
domain of talin 1 is important in both integrin activa-
tion [44,45] and in the intramolecular head–rod inter-
action that is thought to keep cytoplasmic talin 1 in
the autoinhibited form, in which the integrin-binding
sites are masked [46] (B. T. Goult, N. Bate, N. J.
Anthis, K. L. Wegener, A. R. Gingras, B. Patel, I. L.
Barsukov, I. D. Campbell, G. C. K. Roberts & D. R.
Critchley, unpublished results). Clearly, these regula-
tory functions have been lost from both the testis and
kidney short talin 2 isoforms, and in testis, these may
not be required, given the unique architecture and
molecular composition of the ES junctions [42,43].
However, both isoforms contain the second integrin-
binding site in the rod as well as the highly conserved
C-terminal actin-binding site and several vinculin-bind-
ing sites (Fig. 6), and therefore still retain the potential
to link integrins to the actin cytoskeleton.
Evidence has recently come to light regarding the
existence of a microRNA, miR-190, in sense orientation
within intron 51 of mouse Tln2 (ensembl, genome
release 50, gene ENSMUSG00000076379, coordinates
chromosome 9: 67 084 458–67 084 542). MiR-190 is
highly conserved both in sequence and in position in
talin 2 in all vertebrates analysed so far. It is also pres-
ent and expressed from the unique talin gene of insects
(12 Drosophila species [47] and the honey bee, Apis
mellifera [48]), thus conﬁrming the relationship between
the ancestral talin gene and talin 2 [13]. However,
miR-190 is absent in the Caenorhabditis elegans gen-
ome, indicating that miR-190 ﬁrst appeared in the
Arthropod lineage and was maintained throughout the
chordates. Interestingly, miR-190 is expressed in mouse
testis and kidney [49,50], where the two Tln2 short
transcripts are highly expressed, as well as in various
human cell lines [50], and is upregulated in primary
myeloﬁbrosis patients [51]. As miR-190, like many
intronic microRNAs [52], is transcribed as part of
larger primary transcripts, it is possible that one of the
functions of the short Tln2 transcripts is to produce
miR-190. Intriguingly, out of the 36 miR-190 target
genes common to at least two different prediction algo-
rithms and conserved in mammals [51], 12 are genes
involved in cell adhesion or related processes, e.g. mem-
bers of the ARP 2⁄3 complex (ACTR3 and ARPC5),
cadherins (CDH2, PCDH9), myosin VA (MYO5A),
dystroglycan and attractin precursors (DAG1 and
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(HAS2), and KRAS2. Clearly, it will be important to
establish the origin of miR-190 transcripts, and their
expression proﬁle, targets, and function.
In addition to the short talin isoforms, we have also
identiﬁed four alternatively spliced talin 2 transcripts.
Exon 43 is skipped in one variant, and comparison of
talin 1 and talin 2 sequences (74% identity) shows that
this would delete residues 1912–1960, equivalent to
helix 45 and helix 46 of the talin 1 rod (Protein Data
Bank ID: 2b0h). Helix 46 contains one of the numer-
ous vinculin-binding sites (VBS3; Fig. 6) in talin [10],
and deletion of this region would be predicted to
destroy this site. Unfortunately, it has not been possi-
ble to detect the corresponding protein by western
blotting, because the difference in molecular mass
(5.46 kDa) does not allow separation from full-length
talin 2. We have also detected inclusion of exon 54b in
the main talin 2 transcript expressed in brain and at
lower levels in other tissues. The extra 15 amino acids
encoded by exon 54b, which are totally conserved
between mouse and human [13], are inserted into the
N-terminal region of helix 61 of the talin rod. In
talin 1, this helix is part of a ﬁve-helix bundle that
forms the C-terminal actin-binding site [53], and there-
fore the insertion could have important functional
implications (Fig. 6). Clearly, an antibody against the
extra amino acid sequence will be required to establish
whether the corresponding protein is actually expressed
in brain.
In summary, our results demonstrate the complexity
of the mammalian talin 2 gene and provide direct evi-
dence for the existence of at least three different protein
isoforms expressed in a tissue-speciﬁc manner. More-
over, the occurrence of four alternative splicing events
raises the possibility that the number of talin 2 isoforms
is actually much higher. Thus, we currently predict the
existence of six talin 2 variants in addition to the three
short protein isoforms (Fig. 6). This highlights the
need to use isoform-speciﬁc talin 2 antibodies, where
Fig. 6. Diagram of the main talin 2 isoforms. Top: model of full-length talin 2 based on the assumption that the main structural features and
ligand-binding sites of talin 1 are conserved in talin 2. Vinculin-binding sites (VBS) are shown in blue. The consequences of the three main
alternative splicing events detected by RT-PCR for the structure of the long talin 2 isoforms (Figs 5 and S7) are indicated. A red cross indi-
cates that exon 43 skipping ()exon 43) deletes VBS3. A red curved line shows the 15 amino acids inserted into the C-terminal actin-binding
site (ABS3) by the inclusion of exon 54b (+exon 54b). Bottom: structures of the main short talin 2 isoforms predicted to arise from smaller
Tln2 transcripts.
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ies. The results also have important implications for
the design and interpretation of experiments aimed at
deﬁning the expression and the function of talin 2.
First, as there are several Tln2 promoters, the use of
gene traps as reporters of Tln2 expression patterns
should be considered with care. Second, the fact that
the Tln2 gene traps fail to ablate talin 2 expression
indicates that exon skipping may cause problems in
designing Tln2 mutant alleles. Third, the use of small
interfering RNAs downstream of exon 25b or
exon 34b should be avoided, as they will affect expres-
sion of both full-length and the shorter variant(s) of
talin 2. Instead, targeting of transcript-speciﬁc exons
(e.g. 25b, 25c, or 34b) and⁄or promoters might be pre-
ferrable. Fourth, the presence of microRNA miR-190
within the 3¢-region of the Tln2⁄TLN2 gene raises
questions about its function, the role of the short Tln2
transcripts, and the protein isoforms that they encode,
and should also be taken into consideration in the
design of knockout strategies.
Experimental procedures
EST and cDNA analysis
We used the National Institute for Allergy Mouse Gene
Index (version 5) and the Mouse Genome Assembly
through the ensembl portal (build 37; NCBI reference
sequence version 36) to carry out our analysis. The
National Institute for Allergy Mouse Gene Index gene
index provided a graphical view of the Tln2 structure, a list
of all the known and predicted Tln2 exons, and individual
splicing events along with a list of supporting ESTs and
cDNAs. This information was analysed manually and com-
pared with the data present in ensembl. Together, this pro-
vided a framework with which to decipher Tln2 structure,
the existence of short transcripts, and the presence of alter-
native splicing events. It was also used to design the various
primers relevant to the characterization of the gene struc-
ture and described in Table S1.
Promoter prediction
blast was used to identify the sequences equivalent to the
most 5¢ mouse Tln2 exon (exon )7) in human, chimpanzee,
mouse, rat, dog and cow genomic sequences. A 2.2 kb
sequence including the 5¢-end of the CpG island was
extracted from each individual genomic sequence via
ensembl, and analysed using the genomatix promoter
analysis suite (http://www.genomatix.de). Brieﬂy, we used
frameworker and the most stringent settings to identify
the most complex model (framework) of TF-binding sites
that occurred in the same order and in a similar region and
that were common to all six sequences. In addition,
dialign tf [54] was used to identify TF-binding site
matches within the multiple sequence alignments using
default parameters. TF-binding site matches were identiﬁed
by comparison with a matrix of descriptions with
matinspector. To minimize artefacts due to the small size
of TF-binding sites, we increased the threshold of similarity
to the matrix to 0.99, and identiﬁed only TF-binding site
matches that were common to all six sequences.
RNA extraction
Tissues from wild-type C57⁄Bl6 mice were dissected and
stored in RNAlater (Invitrogen, Carlsbad, CA, USA), and
total RNA was extracted from a 20 mg piece of tissue using
the RNAeasy Miniprep kit (Invitrogen), both according to
the manufacturer’s instructions. RNA concentrations were
quantiﬁed at 260⁄280 nm and treated accordingly with
RQ1 DNase I (Promega, Madison, WI, USA; 1 unitÆlg
)1
RNA). After addition of 600 lL of RLT buffer (Invitrogen;
RNAeasy miniprep kit), samples were puriﬁed through a
second RNA column (Invitrogen; RNAeasy miniprep kit)
to eliminate the enzyme. Yields were quantiﬁed at
260⁄280 nm prior to storage at )80  C.
Human RNA, tissue northern blot and kidney
cDNA library
Human foreskin ﬁbroblast and adult heart total RNAs
were a kind gift from K. Clark (University of Leicester,
UK); heart RNA was from Stratagene (Santa Clara, CA,
USA; #540011). One microgram of RNA was reversed
transcribed using a standard protocol (see below). A human
Multiple Tissue Northern Blot was purchased from BD
Biosciences Clontech (Palo Alto, CA, USA) and hybridized
as previously described [12] with a 598 bp mouse cDNA
probe spanning exons 52–55. In order to map the 5¢-end of
the short Tln2 transcript present in human kidney, plasmid
DNA from a human kidney cDNA library (kindly provided
by M. J. A. Tanner, University of Bristol) was screened by
PCR. We took advantage of the directional cloning of the
cDNAs in the vector, and primer SP6-2 in the plasmid
sequence ﬂanking the 5¢-end of the cDNA inserts was used
in combination with primer hT2-3R, designed in reverse
orientation in the TLN2 sequence near the putative 5¢-end
of the short transcript (Table S1). A 450 bp amplicon was
cloned and sequenced.
Reverse transcription
DNAse-treated total RNA (1 lg) was reversed transcribed
with Superscript III (Invitrogen) and random primers
(Promega) as recommended by Invitrogen, with 250 ng of
random primers in a total volume of 20 lL. In addition,
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same conditions by replacing the Superscript III enzyme
with water. One to two microlitres of these reactions was
used in PCRs with the primers described in Table S1. All
primers used to detect cDNA were designed to span at least
one exon–intron boundary, to avoid detection of residual
genomic DNA.
PCR
The ampliﬁcation of small amplicons (< 2 kb) was per-
formed in standard conditions at an annealing temperature
of 55  C, using 600 nm of the primers described in Table S1
and PCR Reddy Mix (ThermoScientiﬁc, Walthman, MA,
USA) in a volume of 15 lL. When a second round of
nested PCR was required, 1 lL of the ﬁrst round was used
in a 15 lL reaction as described above. Long-range PCR
(> 2 kb) was performed using the Expand High Fidelity
PCR kit (Roche, Indianapolis, IN, USA), according to the
manufacturer’s recommendations, with 300 nm of each
primer. One microlitre of these reactions was used subse-
quently as template in a second nested PCR with Reddy-
Mix as described above.
Real-time quantitative RT-PCR
Expression of Tln2 variant mRNAs was quantiﬁed using
real-time PCR in a BioRad MiniOpticon Thermocycler
with 2x iQ SyberGreen Mastermix (BioRad, Hercules, CA,
USA) and the speciﬁc primer sets described in Table S1
and in the ﬁgure legends. Ampliﬁcation conditions, anneal-
ing temperature and primer pair efﬁciency (95–105%), were
optimized for each primer pair prior to the experiment, to
validate the comparison between different primer pairs.
Primers were used at a ﬁnal concentration of 300 nm in a
25 lL reaction volume. One microlitre of random-primed
cDNA from relevant tissues was added to each reaction,
and each cDNA sample was ampliﬁed in triplicate to take
into account variations in ampliﬁcation. Gapdh was used as
an internal normalization control. Relative abundances
were calculated using the 2
)DDCt method [55].
Gene trap ES cells
The gene trap ES cell line RRI4343 (plasmid insertion) was
obtained from BayGenomics (Stamford, CA, USA), and
the FHCRC-S1-D6 gene trap (lentiviral insertion) from
P. Soriano’s laboratory (Seattle, WA, USA). These ES cell
lines were grown in DMEM with 4.5 gÆL
)1 glucose plus
glutamine and 10% fetal bovine serum on 0.1% gelatin
(RRI4343) or mitomycin C-treated MEF feeder layers
(FHCRC-S1-D6) in the presence of 1000 UÆmL
)1 leukae-
mia inhibitory factor, as described previously [19]. The
clones were expanded and stained with X-gal to check for
b-galactosidase expression, and genomic DNA was
extracted and ampliﬁed by PCR to verify the presence of
the correct gene trap insertion. The insertion point of the
gene trap construct in cell line RRI434 was determined by
Chen & Lo [24]. We used this information to design our
own set of genotyping primers, 5¢GT4⁄GT4Vec (gene trap
allele, 450 bp) and 5¢GT4⁄3¢GT4 (wild-type allele, 700 bp;
for sequences, see Table S1), which were used in a single
multiplex PCR. The genomic region upstream of the inser-
tion point of the lentivirus in clone S1-D6 was cloned and
sequenced by P. Soriano’s team, and the sequence informa-
tion provided was used to design primer pairs SGT5¢For⁄
SGT5¢Rev (gene trap allele, 684 bp) and SGT5¢For⁄
SGT3¢Rev (wild-type allele, 536 bp; see sequences in
Table S1), which were used in separate standard PCR
reactions.
Generation of transgenic mice and genotyping
ES cell clones RRI434 and FHRC-S1-D6 were injected into
C57BL⁄6 blastocysts. Germline transmission from male chi-
meras was assessed through the presence of Agouti pups in
the offspring. Animals carrying the gene trap insertions
were identiﬁed by PCR using genomic DNA extracted from
ear snips, using the HotSHOT technique as previously
described [56]. Heterozygous gene trap mice (gt⁄+) were
either outbred onto a C57⁄Bl6 background to establish a
colony or intercrossed in order to generate homozygotes
(gt⁄gt). Combinations of primers (see gene trap ES cells
and Table S1), detecting both the presence and the absence
of the gene trap at the insertion point, allowed discrimina-
tion between heterozygous and homozygous mice.
Protein lysates from tissues and western blotting
Tissues were dissected from genotyped animals, ﬂash frozen
in liquid nitrogen, and stored at )80  C. The frozen tissues
were lysed and homogenized with a Polytron tissue homog-
enizer as described in [57], in the presence of a cocktail of
protease inhibitors (Calbiochem, San Diego, CA, USA;
Set III; 1 : 100 dilution) plus a calpain II inhibitor (E64d;
Sigma, St Louis, MO, USA; 1 lgÆmL
)1). Protein concentra-
tions were determined in 5 lL aliquots in triplicate using
the Bradford assay (Coomassie Plus Kit; ThermoScientiﬁc)
with BSA standards. Aliquots of tissue lysates containing
40 lg of protein were denatured at 100  C for 2 min in the
presence of 5 mm Tris⁄HCl (pH 6.8), 4% glycerol, 1.6%
SDS, 2% bromophenol blue, and 1% b-mercaptoethanol.
The samples were subjected to SDS⁄PAGE (6% gels), and
the proteins were electroblotted onto Hybond P membranes
using wet transfer in 2.5 mm Tris base and 9.6 mm glycine.
Excess protein binding sites were blocked by incubation in
5% dried milk in NaCl⁄Tris (pH 7.4). The long isoform of
talin 2 was detected using a mouse monoclonal antibody
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recombinant mouse talin 2 peptide (amino acids 482–911)
and diluted 1 : 200 in blocking buffer. Polypeptides con-
taining the C-terminal region of talin 2 were detected with
an in-house mouse monoclonal antibody (53-121A1, epi-
tope 2479-2494; 1 : 50 dilution) or a polyclonal antibody
raised in rabbits against residues 2477–2491 of human
talin 2 (1 : 3500 dilution). Vinculin was detected using the
mouse monoclonal antibody F9 as previously described,
with a 1 : 400 dilution [13]. b-Galactosidase was detected
with a rabbit polyclonal primary antibody (Abcam, Cam-
bridge, UK; ab4761, 1 : 1000 dilution). Bound primary
antibodies were detected by adding anti-mouse IgGs (GE
Healthcare UK Ltd, Chalfont St Giles, UK; 1 : 2500 dilu-
tion) or anti-rabbit IgGs (Sigma; A6154, 1 : 3500) coupled
to horseradish peroxidase. Horseradish peroxidase activity
was detected using an ECL Kit (SuperSignal West Pico;
ThermoScientiﬁc), and autoradiographic ﬁlms were exposed
for varying amounts of time. Semiquantitation of the rela-
tive abundance of talin 2 across samples was performed
using Adobe photoshop. Films were scanned and the
images were inverted. Rectangles of constant surface area
were drawn around the talin 2 and vinculin bands, and the
mean luminosity of each rectangle was determined in
Adobe photoshop. Levels of talin 2 were obtained by nor-
malizing the talin 2 to the vinculin signals and by compar-
ing the values between samples.
Cryosections and X-gal staining
Testes were dissected and frozen in optimal cutting tem-
perature (OCT) medium (R. A. Lamb, London, UK) and
20 lm frozen sections were ﬁxed in 2% paraformaldehyde
and 0.1% glutaraldehyde for 5 min, and stained for
b-galactosidase activity overnight at 37  Ci n1· NaCl⁄Pi
with 2.5 mm X-gal, 5 mm potassium ferrocyanide, 5 mm
potassium ferricyanide, 2 mm MgCl2, 2% sodium deoxych-
olate and 0.4% NP-40. The slides were washed three times
in 1 · NaCl⁄Pi, and nuclei were counterstained with hae-
matoxylin. After being rinsed in cold water, the slides were
dehydrated in 70, 90 and 100% ethanol, postﬁxed twice in
xylene, and mounted in DPX synthetic resin.
Seminiferous tubule dissection and X-gal staining
The testis was decapsulated, and the tubules were staged
and dissected as previously described [35]. The relevant por-
tions of tubules were squashed on a slide using a coverslip,
and ﬂash frozen in liquid nitrogen before being ﬁxed in 2%
paraformaldehyde for 5 min. X-gal staining was performed
as described for cryosections, and nuclei were counter-
stained with 4¢,6-diamidino-2-phenylindole dihydrochloride
(DAPI; Invitrogen) for 5 min at room temperature. Slides
were subsequently washed three times in 1 · NaCl⁄Pi
before mounting. Differential interference contrast and
DAPI-stained images were acquired on a Leica DM5000B
microscope ﬁtted with a 40· objective and a Leica
DFC420C imaging system.
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